Irenic Capital Management LP Theravance Biopharma, Inc. Transaction History
Irenic Capital Management LP
- $660 Billion
- Q1 2025
A detailed history of Irenic Capital Management LP transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Irenic Capital Management LP holds 2,760,948 shares of TBPH stock, worth $31 Million. This represents 3.74% of its overall portfolio holdings.
Number of Shares
2,760,948
Previous 2,760,948
-0.0%
Holding current value
$31 Million
Previous $26 Billion
5.1%
% of portfolio
3.74%
Previous 2.79%
Shares
3 transactions
Others Institutions Holding TBPH
# of Institutions
136Shares Held
47.3MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$107 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$83.7 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$53.4 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$42.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$23.3 Million0.0% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $749M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...